Dawn Averitt

Founder and Board Member
Image
Dawn Averitt.

Dawn Averitt began working in the HIV/AIDS arena in 1993, after being diagnosed with HIV in 1988. In addition to being the mother of three daughters, she has founded two non-profit organizations, WISE (Women's Information Service and Exchange) in 1995 and The Well Project in 2002, to improve the lives of women living with HIV and AIDS. As a social justice advocate for people living with HIV and AIDS, Dawn also launched the WRI, which drives "more, better, faster" research in women and has been responsible for many notable achievements such as facilitating the GRACE Study, building network collaborations, guiding FDA labeling decisions, and shaping research and policy priorities at the NIH. In the past 30+ years, she has developed programs to increase awareness, accelerate testing, provide access to treatment, disseminate information and expand clinical trials.

Dawn currently serves on the scientific planning committee for the Conference on Retroviruses and Opportunistic Infections (CROI) and has served on numerous board and panels including as a member of the Perinatal HIV Guidelines Committee from 2007-2012, the Office of AIDS Research Advisory Council (OARAC) from 2008-2012, as well as served two terms on the President's Advisory Council on HIV/AIDS (PACHA) from 2010-2015 during the Obama administration.

Founder and Board Member
Dawn Averitt.

Dawn Averitt began working in the HIV/AIDS arena in 1993, after being diagnosed with HIV in 1988. In addition to being the mother of three daughters, she has founded two non-profit organizations, WISE (Women's Information Service and Exchange) in 1995 and The Well Project in 2002, to improve the lives of women living with HIV and AIDS. As a social justice advocate for people living with HIV and AIDS, Dawn also launched the WRI, which drives "more, better, faster" research in women and has been responsible for many notable achievements such as facilitating the GRACE Study, building network collaborations, guiding FDA labeling decisions, and shaping research and policy priorities at the NIH. In the past 30+ years, she has developed programs to increase awareness, accelerate testing, provide access to treatment, disseminate information and expand clinical trials.

Dawn currently serves on the scientific planning committee for the Conference on Retroviruses and Opportunistic Infections (CROI) and has served on numerous board and panels including as a member of the Perinatal HIV Guidelines Committee from 2007-2012, the Office of AIDS Research Advisory Council (OARAC) from 2008-2012, as well as served two terms on the President's Advisory Council on HIV/AIDS (PACHA) from 2010-2015 during the Obama administration.

Do you get our newsletter?

¿Recibe nuestro boletín?

Sign up for our monthly Newsletter and get the latest info in your inbox.

Suscríbase a nuestro boletín mensual y reciba la información más reciente en su bandeja de entrada.

CAPTCHA
1 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.